Pathogenic variant c.1052T>A (p.Leu351Gln) in adenosine deaminase 2 impairs secretion and elevates type I IFN responsive gene expression

Overview of attention for article published in Frontiers in immunology, September 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 51,683 followers.

RT @SarahMBowers: Happy to share our work on the p.Leu351Gln variant in ADA2, identified in patients with Deficiency of ADA2 @KLBrownLab. O…

24 Oct 2022

Reply Repost Favourite

RT @SarahMBowers: Happy to share our work on the p.Leu351Gln variant in ADA2, identified in patients with Deficiency of ADA2 @KLBrownLab. O…

04 Oct 2022

Reply Repost Favourite

Happy to share our work on the p.Leu351Gln variant in ADA2, identified in patients with Deficiency of ADA2 @KLBrownLab. Our data reveals impaired secretion of L351Q ADA2 and elevated type I IFN responsive gene expression in L351Q ADA2 expressing cells - av

04 Oct 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Pathogenic variant c.1052T>A (p.Leu351Gln) in adenosine deaminase 2 impairs secretion and elevates type I I…

01 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.